[Proceedings: Chemotherapy of malignant gynecologic (ovarian) neoplasms].
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001201:Ascites; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008722:Methods; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D003520:Cyclophosphamide
Chemotherapie maligner gynäkologischer (Ovarial)Tumoren.